Jacob deGrom's MRI Came Back Clean and the Rangers Still Have Not Named His Next Start

Jacob deGrom's MRI on his right triceps came back with encouraging results, and he played catch on Sunday in a session manager Skip Schumaker described as going well. What the Texas Rangers have not done is name a date for his next start, and with the Rangers holding a paper-thin margin in the American League Wild Card race, that silence is the most important thing about this story.

deGrom left his August 13 start against the Angels in Anaheim after two innings, having allowed two earned runs on six hits with a walk and three strikeouts across 53 pitches. He signaled discomfort after a pitch in the second inning, and Schumaker pulled him rather than push through it, later explaining that he was not going to take the risk once the triceps was mentioned. deGrom said afterward that he was not overly concerned and hoped to make his next start.

Clean imaging is genuinely good news, and it should be treated that way. Triceps fatigue that produces no structural finding is the best available outcome from a pitcher leaving a start with arm discomfort.

Why the Rangers are being careful anyway

deGrom's career context is the reason this is a story rather than a footnote. He is the most talented pitcher of his generation when healthy and one of the least available, and Texas has built a rotation plan around managing that reality rather than ignoring it.

A clean MRI does not eliminate the concern with a pitcher whose injury history is what deGrom's is. It changes the question from whether something is torn to whether the underlying fatigue is a symptom of accumulated workload. Those are different problems with different solutions, and the second one is addressed by skipping a start rather than by imaging.

The Rangers' behavior since the injury is consistent with treating it as a workload issue. Playing catch on Sunday and still not announcing a start date on Tuesday is the profile of a team building in an extra turn of rest, not the profile of a team hiding a diagnosis.

The playoff race raises the stakes

Texas is in the tightest section of the American League postseason picture. The Rangers hold a narrow margin for the third Wild Card spot, with Cleveland, Detroit and Minnesota all within roughly a game and a half. That is the kind of race where a single rotation turn decides a season.

That context creates the specific tension the Rangers now have to manage. The rational long-term move with a pitcher of deGrom's injury profile is to give him extra rest whenever there is any doubt. The rational short-term move for a team fighting for a playoff spot in August is to run its ace out there.

Teams in this position usually split the difference: they skip one start, monitor the next bullpen, and return the pitcher on regular rest afterward. If Texas follows that pattern, deGrom misses one turn and is back before the end of the month.

Fantasy fallout

For fantasy managers, deGrom in this state is a hold rather than a start-or-sit decision, and the distinction matters.

A pitcher who has thrown a clean MRI and played catch is not a drop candidate in any format. His per-start value when active is elite, and in a category league the strikeouts he provides across even four or five remaining starts are worth more than any streamer a manager would replace him with.

What managers should not do is bank on a specific date. Roster him, hold an active pitcher slot flexible, and do not build a week's lineup around the assumption that he takes a scheduled turn until the Rangers say so. In weekly-lineup formats, that means treating any deGrom start as a bonus rather than a plan until the rotation is announced.

The secondary fantasy consequence is on the Texas bullpen and on whichever starter takes an extra turn if deGrom is skipped. Spot starters replacing an ace on a contending team are the least appealing streaming targets in baseball, because they inherit tough opponents without the skill to handle them. Avoid the substitute.

The Verdexed model take

Verdexed's pitcher projections apply an availability discount that is specific to injury type rather than generic. Structural findings, ligament and tendon damage, produce large and lasting projection cuts. Fatigue findings with clean imaging produce a small cut to expected starts and essentially no cut to per-start performance.

deGrom falls into the second category, and his rest-of-season projection has moved only slightly. His expected remaining starts came down by roughly one turn. His projected strikeout rate and run prevention when he does pitch are unchanged, because nothing in the reported findings suggests a diminished arm.

The larger model movement is on Texas rather than on deGrom. Verdexed's game-level win probabilities for the Rangers are highly sensitive to which starter takes the mound in a tight race, and a deGrom start versus a replacement start is one of the widest per-game swings any single roster change produces in the American League. In a race decided by a game or two, that is not a rounding error.

The betting angle

The market to watch is Rangers game lines in the days after a rotation announcement. Books price a deGrom start at a significant premium, and correctly so. The inefficiency appears in the other direction: when a team announces a substitute starter late, the line adjustment sometimes lags the actual quality gap, particularly for teams in playoff races where public money is anchored to the team rather than to the pitcher.

The Rangers' postseason odds are the longer-horizon market. If deGrom returns within one skipped start, those odds should firm up, and anyone who bought Texas at a discount during the uncertainty gets paid. If the Rangers extend his absence past the end of August without a clear explanation, the number should move against them meaningfully, because a Wild Card race this tight does not survive losing an ace.

What's next

The next real information is the rotation announcement, and it should come within days. A named start on regular rest means this was a single skipped turn and nothing more. Another week of silence, or a move to the injured list, would change the read entirely and would take a meaningful chunk out of the Rangers' postseason probability.